Global Estimates of Human Papillomavirus Vaccination Coverage by Region and Income Level: A Pooled Analysis
This article, published in The Lancet Global Health, reports on a study that aimed to quantify worldwide cumulative coverage of publicly funded human papillomavirus (HPV) immunization programs and the potential impact on future cervical cancer cases and deaths. They found that many women from high-income and upper-middle-income countries have been vaccinated against HPV, but populations with the highest incidence and mortality of disease remain largely unprotected. The authors conclude that rapid roll-out of the vaccine in low- and middle-income countries might be the only feasible way to narrow present inequalities in cervical cancer burden and prevention.
Author: Bruni L, Diaz M, Barrionuevo-Rosas L, et al.
» Visit web page (English)
(Located at www.thelancet.com)
Citation: Bruni L, Diaz M, Barrionuevo-Rosas L, et al. Global Estimates of Human Papillomavirus Vaccination Coverage by Region and Income Level: A Pooled Analysis. The Lancet Global Health. 2016;4(7):e453-e463.
Resource types: Peer-reviewed journal
Diseases/vaccines: Human papillomavirus (HPV)